New ebola vaccine

The groups include health professionals, the pandemic prevention and fight task force (members of steering committees, people working in quarantining areas, reporters and others), diplomats, and customs and immigration staffs, military personnel, police force, teachers, and the elderly aged over 65.

Others include those working to maintain the supply of essential services such as aviation, transportation, tourism, electricity and water supply, as well as people with chronic diseases,people going abroad on a mission, to work, or study, and those in pandemic-hit areas.

The Ministry of Health (MoH) has announced the plan on the reception, preservation, distribution, and use of COVID-19 vaccines during 2021-2022 with the support of the COVAX Facility – the global procurement mechanism of COVAX.

Vietnam aims to have 80 per cent of its population get vaccinated against COVID-19. However, due to the limited supply, the rate can hit 20 per cent in 2021-2022.

COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), GAVI – the Vaccine Alliance, and the World Health Organization (WHO), alongside key delivery partner UNICEF. Its aim is to accelerate the development and manufacturing of COVID-19 vaccines and to guarantee fair and equitable access for every country in the world.

The COVAX Facility aims to supply COVID-19 vaccines to 190 countries worldwide. On December 10, 2020, GAVI named Vietnam as a member nation. GAVI and COVAX Facility expect to provide COVID-19 vaccines for 20 per cent of the population of member nations.

In spite of this, it is currently estimated that the COVAX Facility will provide the vaccine and materials for vaccination free of charge for 15-16 per cent of the population of 92 countries, including Vietnam. On January 29, the COVAX Facility said that more than 4.8 million doses of COVID-19 vaccine produced by AstraZenecca will be delivered to Vietnam in the first half of this year, while the next delivery will be announced later.

As planned, around 600,000 Vietnamese people, comprising healthcare and COVID-19 combat workers, will be given shots in the first quarter. Meanwhile, 1.8 million customs officers, diplomats, army and police personnel, and teachers will be injected in the second quarter. During the second half, over 16 million teachers and people above 65 will access 33 million doses of vaccines to be provided by the COVAX Facility later.

At a recent online meeting with cities and provinces, Health Minister Nguyen Thanh Long said that in 2021 Vietnam will 150 million doses of the vaccine to ensure sufficient supply. The COVAX Facility has committed to supply 30 million doses for Vietnam this year, mainly used for the remaining six months of the year. AstraZeneca also committed to supply the same doses.

Vietnam stepping up vaccine activities While pushing ahead with locally-made vaccine trials and production, Vietnam is calling on private involvement and resources to quickly increase COVID-19 vaccine supply amid the …

Vietnam to import first batch of Covid-19 vaccine (Infographics) The Drug Administration of Vietnam has approved the import of the first 204,000 doses of the Oxford/AstraZeneca COVID-19 vaccine for emergency use.

PM requests purchasing COVID-19 vaccine in February Prime Minister Nguyen Xuan Phuc has ordered the health sector to conduct all necessary measures to make COVID-19 vaccines available in Vietnam this month either …

Hanoi (VNA) – Prime Minister Nguyen Xuan Phuc has instructed the quick vaccination for people as more than 100,000 doses of COVID-19 vaccine have arrived in Vietnam.

Chairing a Cabinet’s meeting with the National Steering Committee for COVID-19 Prevention and Control in Hanoi on February 24, the PM said Vietnam aims to provide COVID-19 vaccine shots to all people.

However, as the supply of vaccine cannot meet demand at the same time, priority should be given to certain groups in line with the Government’s resolution, he said, stressing the principle of high-risk groups and pandemic-affected areas coming first, followed by those with lower risks.

More vaccine will be imported in the future to serve domestic demands, the PM said while reminding people and authorities at all levels to continue with strict epidemic prevention measures.

He stressed the need to persist with the twin targets of controlling the pandemic and boosting economic development at the same time.

PM Phuc lauded the efforts of localities in controlling the pandemic.

Regarding the “rescue” of goods in Hai Phong, Quang Ninh and Hai Duong, the Government leader asked the Ministry of Industry and Trade to work with Ministry of Agriculture and Rural Development and Ministry of Health to design procedures to quickly sell agricultural products in pandemic-hit localities.

He also requested media agencies to strengthen communications on preventive measures against COVID-19../.

VNA

The vaccine was jointly studied and produced by AstraZeneca pharmaceutical company and the UK’s Oxford University.

Deputy Health Minister Truong Quoc Cuong highlighted the significance of the vaccine delivery at a time when the COVID-19 pandemic is erupting in Hai Duong, Hai Phong and Quang Ninh.

With the delivery, Vietnam has become one of the first countries in Asia to access a prestigious vaccine in the world.

In order to achieve the dual goal of fighting the pandemic and developing the economy, it is necessary to increase vaccination to reach community immunity, he said.

Apart from stepping up the trial and production of vaccines at home, the Health Ministry is working to import more vaccines from other producers as directed by the Government while preparing for vaccination in the priority list, he added.

Vu Thu Ha, Director of the Vietnam Vaccine JSC (VNVC) – importer of the vaccine, said the batch will be brought to the VNVC’s super cold facilities for storage in line with the Government and Health Ministry’s regulations.

Result from clinical trials showed that 22 days after the first shot, AstraZeneca vaccine could fully protect people from serious illness, hospitalization and death caused by the novel coronavirus. Within 90 days, the vaccine’s potency could reach 76 percent.

Analyses showed that the vaccine could reduce infection risk by two thirds for cases without symptoms.

Source: VNA